Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 26Unknown 5Withdrawn 3Terminated 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Uveal Melanoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma 1Glioblastoma 1Burkitt Lymphoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Rituximab 20zanubrutinib 13acalabrutinib 11Magnetic Resonance Spectroscopy 11obinutuzumab 10Specimen Handling 10Cyclophosphamide 10Biopsy 9glofitamab 8Bendamustine Hydrochloride 8pirtobrutinib 7fludarabine 7venetoclax 6orelabrutinib 6ibrutinib 5Lenalidomide 5Cytarabine 5fludarabine phosphate 3Immunotherapy, Adoptive 3CT-P10 3tafasitamab 2polatuzumab vedotin 2loncastuximab tesirine 2brexucabtagene autoleucel 2Whole-Body Irradiation 2Therapeutics 2Prednisone 2Melphalan 2Maintenance 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Mantle-Cell × Carmustine × Clear all
NCT03125642 2025-11-04

Auto Stem Cell Transplant for Lymphoma Patients

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07199296 2025-09-30

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

Ruijin Hospital

Phase 2 Recruiting
45 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡